Diagnostic Values For Club Cell Secretory Protein (CC16) in Serum of Patients of Combined Pulmonary Fibrosis and Emphysema

References

• National Heart, Lung, and Blood Institute. The definition of emphysema. Report of a National Heart, Lung, and Blood Institute, Division of Lung Diseases workshop. Am Rev Respir Dis 1985; 132:182–185.
   PubMed Web of Science ®Google Scholar
• Cardoso WV, Sekhon HS, Hyde DM, Thurlbeck WM. Collagen and elastin in human pulmonary emphysema. Am Rev Respir Dis 1993; 147:975–981.
   PubMed Web of Science ®Google Scholar
• Lang MR, Fiaux GW, Gillooly M, Stewart JA, Hulmes DJ, Lamb D. Collagen content of alveolar wall tissue in emphysematous and non-emphysematous lungs. Thorax 1994; 49:319–326.
   PubMed Web of Science ®Google Scholar
• Lang MR, Fiaux GW, Hulmes DJ, Fiaux GW, Hulmes DJ, Lamb D, Miller A. Quantitative studies of human lung airspace wall in relation to collagen and elastin content. Matrix 1993; 13:471–480.
   PubMedGoogle Scholar
• Belton JC, Crise N, McLaughlin RF, Tueller EE. Ultrastructural alterations in collagen associated with microscopic foci of human emphysema. Hum Pathol 1977; 8:669–677.
   PubMed Web of Science ®Google Scholar
• Fukuda Y, Masuda Y, Ishizaki M, Masugi Y, Ferrans VJ. Morphogenesis of abnormal elastic fibers in lungs of patients with panacinar and centriacinar emphysema. Hum Pathol 1989; 20:652–659.
   PubMed Web of Science ®Google Scholar
• Cottin V, Nunes H, Brillet PY, Delaval P, Devouassoux G, Tilie-Leblond I, Israel-Biet D, Court-Fortune I, Valeyre D, Cordier JF, Groupe d’Etude et de Recherche sur les Maladies Orphielines Pulmoniares (GERM O P). Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J 2005; 26:586–593.
   PubMed Web of Science ®Google Scholar
• Wells AU, King AD, Rubens MB, Cramer D, du Bois RM, Hansell DM. Lone cryptogenic fibrosing alveolitis: a functional-morphologic correlation based on extent of disease on thin-section computed tomography. Am J Respir Crit Care Med 1997; 155:1367–1375.
   PubMed Web of Science ®Google Scholar
• Jankowich MD, Polsky M, Klein M, Cramer D, du Bois RM, Hansell DM, Rounds S. Heterogeneity in combined pulmonary fibrosis and emphysema. Respiration 2008; 75:411–417.
   PubMed Web of Science ®Google Scholar
• Cottin V, Cordier JF. The syndrome of combined pulmonary fibrosis and emphysema. Chest 2009; 136:1–2.
   PubMed Web of Science ®Google Scholar
• Wiggins J, Strickland B, Turner-Warwick M. Combined cryptogenic fibrosing alveolitis and emphysema: the value of high resolution computed tomography in assessment. Respir Med 1990; 84:365–369.
   PubMed Web of Science ®Google Scholar
• Raghu G, Collard HR, Egan JJ, and 30+ other authors. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183:788–824.
   PubMed Web of Science ®Google Scholar
• Hunninghake GM, Hatabu H, Okajima Y, and 20+ other authors. MUC5B promoter polymorphism and interstitial lung abnormalities. N Engl J Med 2013; 368:2192–2200.
   PubMed Web of Science ®Google Scholar
• Mura M, Zompatori M, Pacilli AM, Fasano L, Schiavina M, Fabbri M. The presence of emphysema further impairs physiologic function in patients with idiopathic pulmonary fibrosis. Respir Care 2006; 51:257–265.
   PubMed Web of Science ®Google Scholar
• Mejía M, Carrillo G, Rojas-Serrano J, Estrada A, Suárez T, Alonso D, Barrientos E, Gaxiola M, Navarro C, Selman M. Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension. Chest 2009; 136:10–15.
   PubMed Web of Science ®Google Scholar
• Cottin V, Le Pavec J, Prévot G, Mal H, Humbert M, Simonneau G, Cordier JF, GERM O P. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur Respir J 2010; 35:105–111.
   PubMed Web of Science ®Google Scholar
• Cottin V: The impact of emphysema in pulmonary fibrosis. Eur Respir Rev 2013; 22:153–157.
   PubMedGoogle Scholar
• Broeckaert F, Bernard A. Clara cell secretory protein (CC16): characteristics and perspectives as lung peripheral biomarker. Clin Exp Allergy 2000; 30:469–475.
   PubMed Web of Science ®Google Scholar
• Lee CG, Kang HR, Homer RJ, Chupp G, Elias JA. Transgenic modeling of transforming growth factor-beta(1): role of apoptosis in fibrosis and alveolar remodeling. Proc Am Thorac Soc 2006; 3:418–423.
   PubMedGoogle Scholar
• Raghu G, Collard HR, Egan JJ, and 30 other authors. ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183:788–824.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2013: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Available from: http://www.goldcopd.org/ (accessed 2014 September 4).
   Google Scholar
• Kazerooni EA, Martinez FJ, Flint A, Jamadar DA, Gross BH, Spizamy DL, Cascade PN, Whyte RI, Lynch JP 3rd, Toews G. Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring. AJR Am J Roentgenol 1997; 169:977–983.
   PubMed Web of Science ®Google Scholar
• Pencina MJ, D’Agostino RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med 2004; 23:2109–2123.
   PubMed Web of Science ®Google Scholar
• Liebow AA, Smith DE. New concepts and entities in pulmonary disease. In The Lung, Liebow AA, Smith DE, editors. Baltimore, MD: Williams & Wilkins Co., 1968; 332–365.
   Google Scholar
• Plopper CG, Hyde DM, Buckpitt AR. Clara cells. In: The Lung: Scientific Foundations. 2nd Edn. Edited by Crystal RG, West JB, Weibel ER, and Barnes PJ. Philadelphia: Lippencott-Raven; 1997:517–534.
   Google Scholar
• Hermans C, Bernard A. Lung epithelium-specific proteins: characteristics and potential applications as markers. Am J Respir Crit Care Med 1999; 159:646–678.
   PubMed Web of Science ®Google Scholar
• Ye Q, Fujita M, Ouchi H, Inoshima I, Maeyama T, Kuwano K, Horiuchi Y, Hara N, Nakanishi Y. Serum CC-10 in inflammatory lung diseases. Respiration 2004; 71:505–510.
   PubMed Web of Science ®Google Scholar
• Hasegawa M, Fujimoto M, Hamaguchi Y, Matsushita T, Inoue K, Sato S, Takehara K. Use of serum clara cell 16-kDa (CC16) levels as a potential indicator of active pulmonary fibrosis in systemic sclerosis. J Rheumatol 2011; 38:877–884.
   PubMed Web of Science ®Google Scholar
• Hermans C, Petrek M, Kolek V, Fialová J, Bernard A. Serum Clara cell protein (CC16), a marker of the integrity of the air-blood barrier in sarcoidosis. Eur Respir J 2001; 18:507–514.
   PubMed Web of Science ®Google Scholar
• Janssen R, Sato H, Grutters JC, Bernard A, van Velzen-Blad H, du Bois RM, van den Bosch JM. Study of Clara cell 16, KL-6, and surfactant protein-D in serum as disease markers in pulmonary sarcoidosis. Chest 2003; 124:2119–2125.
   PubMed Web of Science ®Google Scholar
• Lakind JS, Holgate ST, Ownby DR, Mansur AH, Helms PJ, Pyatt D, Hays SM. A critical review of the use of Clara cell secretory protein (CC16) as a biomarker of acute or chronic pulmonary effects. Biomarkers 2007; 12:445–467.
   PubMed Web of Science ®Google Scholar
• Vestbo J, Edwards LD, Scanlon PD, Yates JC, Agusti A, Bakke P, Calverley PM, Celli B, Coxson HO, Crim C, Lomas DA, MacNee W, Miller BE, Silverman EK, Tal-Singer R, Wouters E, Rennard SI, ECLIPSE Investigators. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med 2011; 365:1184–1192.
   PubMed Web of Science ®Google Scholar
• Lomas DA, Silverman EK, Edwards LD, Miller BE, Coxson HU, Tal-Singer R; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators: Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort. Thorax 2008; 63:1058–1063.
   PubMed Web of Science ®Google Scholar
• Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Paré PD. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350:2645–2653.
   PubMed Web of Science ®Google Scholar
• Ohnishi H, Yokoyama A, Kondo K, Hamada H, Abe M, Nishimura K, Hiwada K, Kohno N. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. Am J Respir Crit Care Med 2002; 165:378–381.
   PubMed Web of Science ®Google Scholar
• Inoue Y, Barker E, Daniloff E, Kohno N, Hiwada K, Newman LS. Pulmonary epithelial cell injury and alveolar-capillary permeability in berylliosis. Am J Respir Crit Care Med 1997; 156:109–115.
   PubMed Web of Science ®Google Scholar
• Hirasawa Y, Kohno N, Yokoyama A, Inoue Y, Abe M, Hiwada K. KL-6, a human MUC1 mucin, is chemotactic for human fibroblasts. Am J Respir Cell Mol Biol 1997; 17:501–507.
   PubMed Web of Science ®Google Scholar
• Kohno N, Kyoizumi S, Awaya Y, Fukuhara H, Yamakido M, Akiyama M. New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6. Chest 1989; 96:68–73.
   PubMed Web of Science ®Google Scholar
• Chilosi M, Carloni A, Rossi A, Poletti V. Premature lung aging and cellular senescence in the pathogenesis of idiopathic pulmonary fibrosis and COPD/emphysema. Transl Res 2013; 162:156–173.
   PubMed Web of Science ®Google Scholar